全球內視鏡手術液體管理系統市場－市場規模（依細分市場劃分）、佔有率、監管、報銷、營運數量及預測（至2036年）

本報告深入探討並分析了全球內視鏡手術液體管理系統市場，提供了區域市場規模、關鍵趨勢、創新產品和技術以及競爭格局等資訊。 市場模型的主要組成如下：

已上市的內視鏡手術液體管理系統及不斷演變的競爭格局

• 關鍵產業趨勢探討
• 內視鏡手術液體管理系統市場各細分領域的年度收入和市場預測（2015-2036 年）
• 各細分領域的總營運單位數、銷售量、平均售價及市場價值的詳細資料

全球、區域與國家層面各市場的探討

• 依地區和國家劃分的定性市場資訊及市場分析
• 內視鏡手術液體管理系統市場的 SWOT 分析
• 內視鏡手術液體管理系統市場的競爭動態與趨勢探討

全面的視角，包括對醫療保健系統的概述，有助於更好地理解市場。 此外，市場參與細分還提供有關報銷政策和監管環境的信息，從而可以更深入地了解市場動態。

• 各國醫療保健系統概覽
• 報銷政策
• 醫療科技監管環境

對象企業

• Stryker Corp
• B. Braun Melsungen AG
• Hologic Inc
• Medtronic Plc
• Olympus Corp
• Cardinal Health Inc
• KARL STORZ SE & Co KG
• 其他

Endoscopy Fluid Management Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.

Endoscopy Fluid Management Systems are used for the irrigation and /or aspiration of fluids into or from a surgical work site during an endoscopic procedure. Endoscopy Fluid Management Systems are used during minimally invasive surgery for the purpose of performing any one of a variety of irrigation/aspiration functions such as tissue lavage, uterine distension, and others.

Endoscopy Fluid Management Systems are used during endoscopic examinations such as laparoscopy and hysteroscopy to enhance visibility. The goal of these devices is to improve visibility by managing fluid near and within the surgical site which is accomplished by irrigation and suction. In addition, these devices manage pressure within the surgical site creating favorable operating environments. Irrigation pumps are the most commonly used form of endoscopy fluid management systems; these are used along with endoscopes during minimally invasive (MIS) Interventions.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Endoscopy Fluid Management Systems and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Endoscopy Fluid Management Systems market revenue by segment and market outlooks from 2015-2036.
• Granular data on total installed base, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Endoscopy Fluid Management Systems market.
• Competitive dynamics insights and trends provided for Endoscopy Fluid Management Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Stryker Corp, B. Braun Melsungen AG, Hologic Inc, Medtronic Plc, Olympus Corp, Cardinal Health Inc, KARL STORZ SE & Co KG, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Endoscopy Fluid Management Systems marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Endoscopy Fluid Management Systems market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endoscopy Fluid Management Systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Endoscopy Fluid Management Systems market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.